COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2301: Articles 23001-23010  | Next

Pathogenicity, immunogenicity, and protective ability of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
Wang, P., Lau, S.-Y., Deng, S., Chen, P., Mok, B. W.-Y., Zhang, A. J., Lee, A. C.-Y., Chan, K.-H., Song, W., To, K. K.-W., Chen, J. F.-W., Yuen, K.-Y., Chen, H.
10.1101/2020.08.24.264192 — Posted: 2020-08-24 Discussion: Offsite
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing optimal formation of VLPs in presence of Nucleoprotein
Boson, B., Legros, V., Zhou, B., Mathieu, C., Cosset, F.-L., Lavillette, D., Denolly, S.
10.1101/2020.08.24.260901 — Posted: 2020-08-24 Discussion: Onsite | Offsite
Antiviral activity of lambda-carrageenan against influenza viruses in mice and severe acute respiratory syndrome coronavirus 2 in vitro
Jang, Y. J., Shin, H., Lee, M. K., Kwon, O. S., Shin, J. S., Kim, Y., Kim, M.
10.1101/2020.08.23.255364 — Posted: 2020-08-24
Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients
Westmeier, J., Paniskaki, K., Karaköse, Z., Werner, T., Sutter, K., Dolff, S., Overbeck, M., Limmer, A., Liu, J., Zheng, X., Brenner, T., Berger, M. M., Witzke, O., Trilling, M., Lu, M., Yang, D., Babel, N., Westhoff, T., Dittmer, U., Zelinskyy, G.
10.1101/2020.08.21.262329 — Posted: 2020-08-24 Discussion: Offsite
Examining the status of improved air quality due to COVID-19 lockdown and an associated reduction in anthropogenic emissions
Sannigrahi, S., Molter, A., Kumar, P., Zhang, Q., Basu, B., Basu, A. S., Pilla, F.
10.1101/2020.08.20.20177949 — Posted: 2020-08-24
Control Strategies against COVID-19 in China: Significance of Effective Testing in the Long Run
Lin, Y., Peng, F.
10.1101/2020.08.22.20179697 — Posted: 2020-08-24
Potent anti-SARS-CoV-2 Antibody Responses are Associated with Better Prognosis in Hospital Inpatient COVID-19 Disease
Tighe, P. J., Urbanowicz, R. A., Fairclough, L., McClure, C. P., Thomson, B. J., Gomez, N., Chappell, J. G., Tsoleridis, T., Loose, M., Carlile, M., Moore, C., Holmes, N., Sang, F., Hrushikesh, D., Clark, G., Temperton, N., Brooks, T., Ball, J. K., Irving, W. L., Tarr, A. W.
10.1101/2020.08.22.20176834 — Posted: 2020-08-24
Impact of population density on Covid 19 infected and mortality rate in India
Bhadra, A., Mukherjee, A., Sarkar, K.
10.1101/2020.08.21.20179416 — Posted: 2020-08-24
Modeling Hospital Energy and Economic Costs for COVID-19 Infection Control Interventions
Squire, M. M., Munsamy, M., Lin, G., Telukdarie, A., Igusa, T.
10.1101/2020.08.21.20178855 — Posted: 2020-08-24
The impact of COVID-19 on acute Trauma and Orthopaedic referrals and surgery in the UK: the "golden peak weeks" of the first national multi-centre observational study. The COVid-Emergency Related Trauma and orthopaedics (COVERT) Collaborative
Sugand, K., COVERT Collaborative
10.1101/2020.08.22.20179770 — Posted: 2020-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).